Afuco™ Anti-Human APLN ADCC Therapeutic Antibody, ADCC Enhanced

Anti-APLN ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antigen-binding protein may comprise an antibody to apelin and can be used to treat pathological conditions involving angiogenesis. The pathological conditions can comprise cancer or retinopathy and/or retinopathy- related complications.
Supplier Creative Biolabs
Product # AFC-046CL
Pricing Inquiry
Host Humanized
Target APLN
Species Reactivity Human
Type ADCC enhanced antibody
Storage 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided.
Feedback